DUOSYNC Trademark

Trademark Overview


On Friday, March 30, 2012, a trademark application was filed for DUOSYNC with the United States Patent and Trademark Office. The USPTO has given the DUOSYNC trademark a serial number of 85584519. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 6, 2022. This trademark is owned by Glaxo Group Limited. The DUOSYNC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculo...
duosync

General Information


Serial Number85584519
Word MarkDUOSYNC
Filing DateFriday, March 30, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 6, 2022
Registration Number4834280
Registration DateTuesday, October 20, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkDUO SYNC
Translation of Words in MarkThe wording "DUOSYNC" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Friday, May 6, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, October 20, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 20, 2015REGISTERED-PRINCIPAL REGISTER
Monday, September 14, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, September 10, 2015NOTICE OF ALLOWANCE CANCELLED
Thursday, September 10, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2015SOU EXTENSION 5 GRANTED
Thursday, March 26, 2015SOU EXTENSION 5 FILED
Thursday, March 26, 2015TEAS EXTENSION RECEIVED
Saturday, October 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 3, 2014SOU EXTENSION 4 GRANTED
Tuesday, September 30, 2014SOU EXTENSION 4 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Saturday, April 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 4, 2014SOU EXTENSION 3 GRANTED
Tuesday, April 1, 2014SOU EXTENSION 3 FILED
Tuesday, April 1, 2014TEAS EXTENSION RECEIVED
Wednesday, October 30, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2013SOU EXTENSION 2 GRANTED
Wednesday, September 25, 2013SOU EXTENSION 2 FILED
Friday, October 25, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 25, 2013TEAS EXTENSION RECEIVED
Friday, April 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2013SOU EXTENSION 1 GRANTED
Wednesday, April 3, 2013SOU EXTENSION 1 FILED
Wednesday, April 3, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 16, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 23, 2012ASSIGNED TO EXAMINER
Friday, April 6, 2012NOTICE OF PSEUDO MARK MAILED
Thursday, April 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 3, 2012NEW APPLICATION ENTERED IN TRAM